Discordant expression of myeloid antigens and myeloperoxidase in a case of t(8;21) positive AML expressing CD7

International Journal of Hematology

Volumn 70, Issue 1, 1999, Pages 30-35

  Hirai, Katsuyuki ^a   Torimoto, Yoshihiro ^a   Moriichi, Kentaro ^a   Sato, Kazuya ^a   Ohnishi, Kouhei ^a   Taya, Noriyasu ^a   Kohgo, Yutaka ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Acute myeloid leukemia; Myeloid antigen; Myeloperoxidase; T(8; 21) (q22; q22)

Indexed keywords

CD33 ANTIGEN; DIFFERENTIATION ANTIGEN; DNA; LEUKOCYTE ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PEROXIDASE; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME ABERRATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MOLECULAR GENETICS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AMINO ACID SEQUENCE; ANTIGENS, CD; ANTIGENS, CD13; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ANTIGENS, NEOPLASM; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOCYTIC, ACUTE; MOLECULAR SEQUENCE DATA; PEROXIDASE; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033162264     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:620-5.
2. Griffin JD, Davis R, Nelson DA, et al. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia. Blood 1986;68:1232-41.
3. Koeffler HP, Ranyard J, Pertcheck M. Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 1985;65:484-91.
4. Fourth International Workshop on Chromosomes in Leukemia, 1982. Translocation (8;21) (q22:q22) in acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1984;11:284-7.
5. Second MIC Cooperative Study Group. Morphologic, immunologie, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet Cytogenet 1988;30:1-15.
6. Bitter MA, Le Beau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol 1987;18:211-25.
7. Second International Workshop on Chromosomes in Leukemia, 1979. Cytogenetic, morphologic, and clinical correlations in acute nonlymphocytic leukemia with t(8q-;21q+). Cancer Genet Cytogenet 1980;2:89-102.
8. Erickson PF, Dessev G, Lasher RS, Philips G, Robinson M, Drabkin HA. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood 1996;88:1813-23.
9. Miyoshi H, Kozu T, Shimizu K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993;12:2715-21.
10. Kurokawa M, Tanaka T, Tanaka K, et al. A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts. JBC 1996;271:16870-6.
11. Nuchprayoon I, Meyers S, Scott LM,et al. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ protooncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Moll Cell Biol 1994;14:5558-68.
12. Seshi B, Kashyap A, Bennett JM. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-). Br J Haematol 1992;81:374-7.
13. -. Intern Med 1993;32:733-6.